Improper Use Of Fentora Can Be Deadly: Cephalon VP

Law360, New York (September 14, 2007, 12:00 AM EDT) -- Jeffrey Dayno, vice president of pharmaceutical company Cephalon Inc., warned doctors in a letter on Monday that its pain drug Fentora carried a risk of serious health complications and even death if not used correctly.

“We have recently learned of serious adverse events, including deaths in patients treated with Fentora,” Dayno said. “These deaths occurred as a result of improper patient selection (e.g., use in opioid non-tolerant patients), improper dosing, and/or improper product subsitution.”

Dayno went on to include information on how to avoid risks associated...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.